Valeant Pharma (VRX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	75.38M
Marketable securities	0
Accounts receivable, net	183.79M
Inventories, net	134.04M
Assets held for sale	1.56M
Prepaid expenses	16.51M
Current deferred tax assets, net	87.74M
Income taxes receivable	4.17M
Total current assets	503.19M
Property, plant and equipment, net	155.21M
Deferred tax assets, net	4.92M
Goodwill	361.13M
Intangible assets, net	840.83M
Other assets	22.83M
Total non-current assets	1.38B
Total assets	1.89B
Trade payables	49.73M
Accrued liabilities	228.21M
Notes payable and current portion of long-term debt	82.28M
Deferred revenue	17.77M
Income taxes payable	10.08M
Current deferred tax liabilities, net	759K
Current liabilities for uncertain tax positions	646K
Total current liabilities	389.49M
Long-term debt, less current portion	955.58M
Deferred revenue	621K
Deferred tax liabilities, net	106.93M
Liabilities for uncertain tax positions	16.74M
Other liabilities	65.74M
Total non-current liabilities	1.15B
Total liabilities	1.54B
Commitments and contingencies	0
Common stock	759K
Additional capital	922.94M
Accumulated deficit	-573.77M
Accumulated other comprehensive income	3.07M
Total Valeant stockholders' equity	352.99M
Noncontrolling interest	22K
Total stockholders' equity	353.01M
Total liabilities and stockholders' equity	1.89B

Entities mentioned with VRX

View All Entities